Cargando…
Development of Nasal Vaccines and the Associated Challenges
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong mucosal and systemic immunity to combat these infections. The intranasal route of vaccination offers the advantage of ea...
Autores principales: | Nian, Xuanxuan, Zhang, Jiayou, Huang, Shihe, Duan, Kai, Li, Xinguo, Yang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609876/ https://www.ncbi.nlm.nih.gov/pubmed/36297419 http://dx.doi.org/10.3390/pharmaceutics14101983 |
Ejemplares similares
-
The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review
por: Zhang, Jiayou, et al.
Publicado: (2022) -
Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model
por: Yang, Baifeng, et al.
Publicado: (2023) -
AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice
por: Nian, Xuanxuan, et al.
Publicado: (2021) -
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
por: Fan, Renfeng, et al.
Publicado: (2021) -
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
por: Huang, Xiaoyuan, et al.
Publicado: (2022)